Blood Test For Cancer Gives New Life To Guardant Health Shares
Copyright 2022 Forbes Media LLC
business
2022-10-17 16:07:14

Blood draw (Photo by Jon Cherry/Getty Images)Getty Images
Researchers are making real progress diagnosing cancer with a simple blood test. It is a game-changer in healthcare, and a big deal for investors. Results published in September from a new medical study show that researchers have developed a DNA blood test that is 99.1% effective screening for several types of cancer. Investors should consider buying Guardant Health Inc. (GH). Screening for cancer with a simple blood test used to be the stuff of science fiction.
